Dublin, July 16, 2019 (GLOBE NEWSWIRE) -- The "Cell Culture Market by Product (Consumables (Media, FBS), Equipment (Bioreactor, Centrifuge, Incubator, Microscope, Autoclave)), Application (Stem Cell, Vaccines, Therapeutic proteins), End User - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The cell culture market is expected to reach USD 29.17 billion by 2024 from USD 16.02 billion in 2019, at a CAGR of 12.7%.
This report provides a detailed picture of the global cell culture market. It aims at estimating the size and future growth potential of the market across different segments, such as product, application, end-user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Increasing funding for cell-based research, growing benefits of the cell culture-based vaccines, and rising demand for monoclonal antibodies are expected to drive the overall growth of the cell culture market
This market is experiencing significant growth due to the growing awareness about the benefits of cell culture-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, growing focus on personalized medicine, and the launch of advanced cell culture products. On the other hand, the high cost of cell biology research and the lack of proper infrastructure for cell-based research activities are the major factors restraining the growth of this market.
Pharmaceutical and biotechnology companies are expected to dominate the market during the forecast period
Based on end-user, the cell culture market is segmented into research institutes, pharmaceutical & biotechnology companies, cell banks, and hospitals & diagnostic laboratories. In 2018, pharmaceutical and biotechnology companies accounted for the largest share of the cell culture market. The growing use of single-use technologies, increasing number of regulatory approvals for cell culture-based vaccines, and the presence of a large number of pharmaceutical players in this market are some of the factors driving the cell culture market for pharmaceutical and biotechnology companies.
Biopharmaceutical production to witness the highest growth in the cell culture market
Based on application, the cell culture market is categorized into biopharmaceutical production, stem cell research, diagnostics, drug discovery & development, tissue engineering & regenerative medicine, and other applications. The biopharmaceutical production segment is also expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the commercial expansion of major pharmaceutical companies, growing regulatory approvals for the production of cell culture-based vaccines, and increasing demand for monoclonal antibodies (mAbs).
North America to dominate the market during the forecast period
Geographically, the cell culture market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2018, North America accounted for the largest share of the cell culture market. The growing regulatory approvals for cell culture-based vaccines, technological advancements, growth in the biotechnology and pharmaceutical industries, higher investments in cell-based research, rising incidence of diseases such as cancer, strong government support, and conferences and symposiums that create awareness on the latest trends in cell culture technology are the key factors driving the growth of the cell culture market in North America.
Key Topics Covered
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitation
1.6 Stakeholders
2 Research Methodology
2.1 Research Data
2.2 Secondary Data
2.2.1 Secondary Source
2.3 Primary Data
2.3.1 Key Data From Primary Sources
2.4 Market Size Estimation
2.5 Market Breakdown and Data Triangulation
2.6 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Cell Culture: Market Overview
4.2 Asia Pacific: Cell Culture Market Share, By End User and Country (2019)
4.3 Cell Culture Sera, Media, & Reagents Market, By Type (USD Billion)
4.4 Cell Culture Market, By Application, 2019 vs 2024 (USD Billion)
4.5 Cell Culture Market, By Product, 2019 vs 2024 (USD Billion)
4.6 Geographical Snapshot of the Cell Culture Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Growing Awareness About the Benefits of Cell Culture-Based Vaccines
5.2.1.2 Increasing Demand for Monoclonal Antibodies
5.2.1.3 Funding for Cell-Based Research
5.2.1.4 Growing Preference for Single-Use Technologies
5.2.1.5 Launch of Advanced Cell Culture Products
5.2.1.6 Growing Focus on Personalized Medicine
5.2.2 Market Restraints
5.2.2.1 High Cost of Cell Biology Research
5.2.2.2 Lack of Infrastructure for Cell-Based Research in Emerging Economies
5.2.3 Market Opportunities
5.2.3.1 Growing Demand for 3D Cell Culture
5.2.3.2 Increased Risk of Pandemics and Communicable Diseases
5.2.3.3 Emerging Economies
6 Cell Culture Market, By Product
6.1 Introduction
6.2 Consumables
6.2.1 Sera, Media, and Reagents
6.2.1.1 Media
6.2.1.1.1 Serum-Free Media
6.2.1.1.1.1 Lack of Sera Eliminates the Risk of Contamination By Viruses
6.2.1.1.2 Classical Media & Salts
6.2.1.1.2.1 Classical Media is Commonly Used in Diagnostics and Manufacturing
6.2.1.1.3 Stem Cell Culture Media
6.2.1.1.3.1 Stem Cell Culture Media Will Witness the Highest Growth in the APAC Market
6.2.1.1.4 Specialty Media
6.2.1.1.4.1 Specialty Media is Suitable for Specific, Selective Cell Types
6.2.1.2 Reagents
6.2.1.2.1 Supplements & Growth Factors
6.2.1.2.1.1 Supplements Such as Amino Acids Play A Key Role in Inducing Cell Growth
6.2.1.2.2 Buffers & Chemicals
6.2.1.2.2.1 Chemical Buffers are Widely Used, But are Expensive and Can Be Toxic
6.2.1.2.3 Cell Dissociation Reagents
6.2.1.2.3.1 Dissociation Reagents Can Be Enzymatic Or Non-Enzymatic
6.2.1.2.4 Balanced Salt Solutions
6.2.1.2.4.1 Salt Solutions Find Wide Applications in Life Sciences
6.2.1.2.5 Attachment & Matrix Factors
6.2.1.2.5.1 Development of Cells is Dependent on Attachment Factors
6.2.1.2.6 Antibiotics/Antimycotics
6.2.1.2.6.1 Possibility of Toxicity and Contamination Risks Make Long-Term Use of Antibiotics/Antimycotics Conditional
6.2.1.2.7 Contamination Detection Kits
6.2.1.2.7.1 Kits Provide Results in Hours, Much Faster Than Direct Culture Methods
6.2.1.2.8 Cryoprotective Reagents
6.2.1.2.8.1 Inorganic Expansions are A Favored Strategy for Companies in This Market
6.2.1.2.9 Other Cell Culture Reagents
6.2.1.3 Sera
6.2.1.3.1 Fetal Bovine Sera
6.2.1.3.1.1 Use of Fbs is Associated With Ethical Issues
6.2.1.3.2 Adult Bovine Sera
6.2.1.3.2.1 ABS is Used as A Biochemical Agent in Ivd
6.2.1.3.3 Other Animal Sera
6.2.2 Vessels
6.2.2.1 Roller/Roux Bottles
6.2.2.1.1 Roller Bottles Offer an Economical Means of Cultivating Large Cell Volumes
6.2.2.2 Cell Factory Systems/Cell Stacks
6.2.2.2.1 Cell Stacks Require Special Handling Equipment and Skilled Expertise
6.2.2.3 Multiwell Plates
6.2.2.3.1 Larger Well Formats Allow for Greater Culture Volumes
6.2.2.4 Flasks
6.2.2.4.1 Disposable Flasks are in Greater Demand Among End Users
6.2.2.5 Petri Dishes
6.2.2.5.1 Wide Usage of Petri Dishes is Attributed to Their Ease of Use
6.2.3 Bioreactor Accessories
6.3 Equipment
6.3.1 Supporting Equipment
6.3.1.1 Filtration Systems
6.3.1.1.1 Growing Research in Cell Biology is A Key Factor Driving Market Growth
6.3.1.2 Cell Counters
6.3.1.2.1 Automated Cell Counters are Witnessing Growing Demand
6.3.1.3 Carbon Dioxide Incubators
6.3.1.3.1 Incubators Provide Control Over Atmospheric Conditions for Best Effect
6.3.1.4 Centrifuges
6.3.1.4.1 Technological Advances have Enabled the Development of Faster, More Effective Centrifuges
6.3.1.5 Autoclaves
6.3.1.5.1 Autoclaves Sterilize Equipment and Supplies for Use
6.3.1.6 Microscopes
6.3.1.6.1 Inverted Microscopes are Widely Used in Cell Culture Processes
6.3.1.7 Biosafety Cabinets
6.3.1.7.1 Cabinets are Classified Into Three Classes Based on Protection Offered
6.3.1.8 Other Supporting Equipment
6.3.2 Bioreactors
6.3.2.1 Conventional Bioreactors
6.3.2.1.1 Conventional Bioreactors Hold the Largest Share of the Bioreactors Market
6.3.2.2 Single-Use Bioreactors
6.3.2.2.1 Convenience, Ease of Use, and Flexibility are Driving Demand for Single-Use Bioreactors
6.3.3 Storage Equipment
6.3.3.1 Refrigerators & Freezers
6.3.3.1.1 Refrigerators & Freezers are Used for Both Short and Long-Term Storage
6.3.3.2 Cryostorage Systems
6.3.3.2.1 Benefits of Long-Term Preservation of Cell Cultures are Driving Market Growth
7 Cell Culture Market, By Application
7.1 Introduction
7.2 Biopharmaceutical Production
7.2.1 Therapeutic Proteins
7.2.1.1 Growing Applications of Recombinant Proteins to Drive This Segment
7.2.2 Vaccine Production
7.2.2.1 Rising Incidence of Disease Outbreaks to Drive the Market for Vaccine Production
7.3 Diagnostics
7.3.1 Cell Cultures are Used in the Diagnosis of Viral Diseases
7.4 Drug Screening and Development
7.5 Stem Cell Research
7.5.1 Stringent Regulations to Conduct Clinical Trials for New Stem Cell-Based Therapies on Human Subjects is Restraining the Growth of This Segment
7.6 Tissue Engineering & Regenerative Medicine
7.7 Other Applications
8 Cell Culture Market, By End User
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.2.1 Increasing Use of Single-Use Technologies is Driving the Growth of the Cell Culture Market for This Segment
8.3 Hospitals and Diagnostic Laboratories
8.3.1 Increasing Awareness for the Diagnosis of Various Diseases to Drive This Segment
8.4 Research Institutes
8.4.1 Increasing Government Funding for Research Projects and High Prevalence of Cancer to Drive the Cell Culture Market for Research Institutes
8.5 Cell Banks
8.5.1 Increasing Awareness of Preserving Stem Cells to Drive This Segment
9 Cell Culture Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 US to Dominate the North American Cell Culture Market
9.2.2 Canada
9.2.2.1 Advancement in the Field of Regenerative Medicine to Drive the Cell Culture Market in Canada
9.3 Europe
9.3.1 Germany
9.3.1.1 Increasing Investment By Various Key Players and Growing Funding From Government Organizations to Drive the Market
9.3.2 France
9.3.2.1 Support From Government and Private Investors to Drive the Market for Cell Culture in France
9.3.3 UK
9.3.3.1 Growth in the Life Science Industry to Drive the Market for Cell Culture in the UK
9.3.4 Italy
9.3.4.1 Increasing Number of Cell Biology Seminars and Conferences to Fuel the Adoption of Cell Culture Products
9.3.5 Spain
9.3.5.1 Increasing Funding From Private and Public Organizations to Aid Market Growth
9.3.6 RoE
9.4 Asia Pacific
9.4.1 Japan
9.4.1.1 Strategic Developments By Companies to Drive the Market for Cell Culture in Japan
9.4.2 China
9.4.2.1 Government Initiatives and Strategic Initiatives By Key Players to Strengthen the Biotechnology Industry in China
9.4.3 India
9.4.3.1 Growth Initiatives to Promote Life Science Industry to Drive the Market for Cell Culture in India
9.4.4 RoAPAC
9.5 Rest of the World (RoW)
10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis, 2018
10.3 Competitive Scenario
10.3.1 Partnerships, Agreements, and Collaborations (2016-2019)
10.3.2 Product Launches (2016-2019)
10.3.3 Expansions (2016-2019)
10.3.4 Acquisitions (2016-2019)
10.4 Competitive Leadership Mapping (2019)
10.4.1 Vendor Inclusion Criteria
10.4.2 Vanguards
10.4.3 Innovators
10.4.4 Dynamic Players
10.4.5 Emerging Players
11 Company Profiles
11.1 Becton, Dickinson and Company
11.2 Cellgenix
11.3 Corning
11.4 Danaher
11.5 Eppendorf
11.6 Fujifilm Irvine Scientific (Acquired By Fujifilm Corporation)
11.7 GE Healthcare (A Subsidiary of General Electric Company)
11.8 Hi-Media Laboratories
11.9 Invivogen
11.10 Lonza Group AG
11.11 Merck KGaA
11.12 Miltenyi Biotec
11.13 Promocell
11.14 Sartorius AG
11.15 Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/r/yteem6
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.